Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
30.7M
-
Shares change
-
+883K
-
Total reported value, excl. options
-
$251M
-
Value change
-
+$6.17M
-
Number of buys
-
40
-
Number of sells
-
-60
-
Price
-
$8.15
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q4 2017
128 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q4 2017.
ENZO BIOCHEM INC - Common Stock (ENZB) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.7M shares
of 52.3M outstanding shares and own 58.8% of the company stock.
Largest 10 shareholders include Evermore Global Advisors, LLC (4.56M shares), WELLINGTON MANAGEMENT GROUP LLP (4.29M shares), BlackRock Inc. (3.65M shares), RENAISSANCE TECHNOLOGIES LLC (2.34M shares), DIMENSIONAL FUND ADVISORS LP (2.09M shares), Vanguard Group Inc (1.9M shares), GILDER GAGNON HOWE & CO LLC (1.08M shares), ACADIAN ASSET MANAGEMENT LLC (916K shares), STATE STREET CORP (720K shares), and TIAA CREF INVESTMENT MANAGEMENT LLC (652K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.